Abnormal expression of AChE has been observed in malignant grade III brain tumors [57], type IV glioma [58], lung cancer [59], retinoblastoma [60], squamous cell carcinoma [60], and human tumor cell lines of different tissue origin [61]. This evidence concerns the gene ACHE and central nervous system cancer.